MOORE CAPITAL MANAGEMENT, LP - ARIAD PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
MOORE CAPITAL MANAGEMENT, LP ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$685,000
-66.8%
50,000
-83.3%
0.02%
-63.1%
Q4 2014$2,061,000
+27.2%
300,0000.0%0.06%
+71.1%
Q3 2014$1,620,000
-15.2%
300,0000.0%0.04%
-17.4%
Q2 2014$1,911,000
+107.7%
300,000
+500.0%
0.05%
+130.0%
Q3 2013$920,000
-29.9%
50,000
-33.3%
0.02%
-35.5%
Q2 2013$1,312,00075,0000.03%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,850,000$175,916,00040.51%
Consonance Capital Management LP 8,695,742$119,045,00011.46%
Tamarack Advisers, LP 3,700,000$49,358,0007.76%
Opaleye Management Inc. 1,045,000$14,306,0007.49%
Granite Point Capital Management, L.P. 457,415$6,262,0002.44%
Redmile Group, LLC 2,138,471$29,276,0002.33%
IRONWOOD INVESTMENT MANAGEMENT LLC 206,010$2,820,0002.17%
Palo Alto Investors LP 2,587,617$35,424,0002.06%
PRICE MICHAEL F 940,000$12,869,0001.71%
HighVista Strategies LLC 638,086$8,735,0001.62%
View complete list of ARIAD PHARMACEUTICALS INC shareholders